CD57 Antikörper (AA 35-84)
Kurzübersicht für CD57 Antikörper (AA 35-84) (ABIN1453098)
Target
Alle CD57 (B3GAT1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 35-84
-
Spezifität
-
CD57 antibody detects endogenous levels of CD57.
-
Aufreinigung
- The antibody was purified from rabbit antiserum by affinity-chromatography using immunogen.
-
Immunogen
- The antiserum was produced against synthesized peptide derived from human CD57.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC: 1:50~1:100 ELISA: 1:10000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable at -20°C for at least 1 year.
-
-
- CD57 (B3GAT1) (beta-1,3-Glucuronyltransferase 1 (Glucuronosyltransferase P) (B3GAT1))
-
Andere Bezeichnung
- CD57
-
Hintergrund
-
Synonyms: Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1, Beta-1,3-glucuronyltransferase 1, Glucuronosyltransferase-P, GlcAT-P, UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase, GlcUAT-P, B3GAT1, GLCATP
NCBI Gene Symbol: B3GAT1
-
Molekulargewicht
- 38 kDa
-
Gen-ID
- 27087
-
OMIM
- 151290
-
UniProt
- Q9P2W7
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-